CORCORAN & ASSOCIATES, INC. DBA CORCORAN PARTNERS

Lobbying for NOVARTIS · Bio-pharmaceutical company

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $50,000.00 income · posted Oct 20, 2025

Bills named in this filing 1

Lobbying activity 2

Health Issues

Support for H.R. 1672 - Maintaining Investments in New Innovation Act (MINI Act)

Medicare/Medicaid

Support for H.R. 1672 - Maintaining Investments in New Innovation Act (MINI Act)

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.